Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry

Prior-Espanol, A; Sanchez-Piedra, C; Campos, J; Manero, FJ; Perez-Garcia, C; Bohorquez, C; Busquets-Perez, N; Blanco-Madrigal, JM; Diaz-Torne, C; Sanchez-Alonso, F; Mateo, L; Holgado-Perez, S

Prior-Espanol, A (corresponding author), Hosp Badalona Germans Trias & Pujol, Rheumatol Unit, Carretera Canyet S-N, Barcelona 08916, Spain.

SCIENTIFIC REPORTS, 2021; 11 (1):

Abstract

Biologic and targeted synthetic disease-modifying antirheumatic drugs (ts/bDMARDs) play a pivotal role in the treatment of rheumatoid arthritis (RA), ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索